Effect of cisplatin on dopamine release from PC12 cells

Life Sciences

Volumn 59, Issue 21, 1996, Pages 1793-1801

  Kasabdji, Dyabra ^b   Shanmugam, Vedapuri ^a   Rathinavelu, Appu ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

anticancer drugs; cisplatin; dopamine; PC12 cells

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM; CARBACHOL; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOPAMINE; EMETIC AGENT; POTASSIUM CHLORIDE; VERAPAMIL;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG ANTAGONISM; DRUG POTENTIATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PHEOCHROMOCYTOMA CELL; RAT; VOMITING;

ANIMALIA;

EID: 0030592527     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00522-X     Document Type: Article

References (13)

1. 1. A.S. ABRAHAM, S.B. KAYE, T. SOWERBUTTE, C. FREWIN, and R.M. FOX, Eur. J. Cancer Clin. Oncol. 19 203-208 (1983)
2. 2. L.J. SIEGEL and D.L. LONGO, Ann. Int. Med. 95 352-359 (1981)
3. 3. S. FRYTAK and C.G. MOERTAL, J. Amer. Med. Assoc. 245 393-396 (1981)
4. 4. W.D. FIGG and J.M. FIGG, U.S. Pharmacist 19 54-82 (1994)
5. 5. L.X. CUBEDDU, I.S. HOFFMAN, T. FUENMAYOR, A.L. FINN, N. Eng. J. Med. 22 810-816 (1990)
6. 6. S.M. SAGAR, Cancer Treat. Rev. 18 95-135 (1991)
7. 7. K.L. FUIJITA, L. LAZAROVICI and G. GUROFF, Environ. Health. Perspec. 80 127 (1989)
8. 8. L.A. GREENE and G. REIN, Brain. Res. 138 521-528 (1977)
9. 9. P.L.R. ANDREWS, and C.J. DAVIS, The mechanism of emesis induced by anticancer therapies, P.L.R. ANDREW and G.J. SANGER (Eds.), 113-162, Chapman and Hall Medical, London (1993)
10. 10. K. RACKE and H. SCHWORER, Clin. Investig., 70 190-200 (1993)
11. 11. K. RACKE and H. SCHWORER, Pharmacol. Res., 21 13-25 (1990)
12. 12. L.K. TAY, C.L. BREGMAN, B.A. MASTERS, and P.D. WILLIAMS, Cancer Chemother. Pharmacol. 15 93 (1988)
13. 13. J.G. ZHANG and W.E. LINDUP, Biochem. Pharmacol. 47 1127-1135 (1994)